RE
TEVA icon

RBC Europe’s Teva Pharmaceuticals TEVA Stock Holding History

RBC Europe’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$15K Hold
1,981
– – ﹤0.01% 459
2022
Q1 		$19K Hold
1,981
– – ﹤0.01% 464
2021
Q4 		$16K Sell
1,981
-3,571
-64% -$32.2K ﹤0.01% 481
2021
Q3 		$54.1K Hold
5,552
– – ﹤0.01% 554
2021
Q2 		$55K Sell
5,552
-11,912
-68% -$126K ﹤0.01% 570
2021
Q1 		$202K Hold
17,464
– – 0.01% 295
2020
Q4 		$169K Hold
17,464
– – 0.01% 310
2020
Q3 		$157K Sell
17,464
-7,864
-31% -$83.2K 0.01% 289
2020
Q2 		$312K Buy
25,328
+975
+4% +$11K 0.02% 196
2020
Q1 		$219K Hold
24,353
– – 0.02% 200
2019
Q4 		$239K Buy
24,353
+373
+2% +$3.33K 0.02% 229
2019
Q3 		$165K Buy
23,980
+869
+4% +$6.66K 0.02% 263
2019
Q2 		$213K Sell
23,111
-350
-1% -$4.22K 0.02% 244
2019
Q1 		$368K Sell
23,461
-327
-1% -$5.77K 0.04% 177
2018
Q4 		$367K Sell
23,788
-400
-2% -$8.2K 0.05% 158
2018
Q3 		$521K Buy
24,188
+432
+2% +$10K 0.06% 154
2018
Q2 		$578K Hold
23,756
– – 0.07% 144
2018
Q1 		$406K Sell
23,756
-5,898
-20% -$115K 0.05% 170
2017
Q4 		$562K Buy
29,654
+5,000
+20% +$75.2K 0.07% 147
2017
Q3 		$434K Buy
+24,654
New +$555K 0.06% 164

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

RBC Europe's TEVA Position: Q2 2022 in Review

RBC Europe held its Teva Pharmaceuticals (TEVA) position steady in Q2 2022 at 1,981 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #459.

RBC Europe first reported a position in TEVA in Q3 2017 and has held it in 20 quarters since. The position peaked at $578K in Q2 2018. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2022.

  • RBC Europe held 1,981 shares of Teva Pharmaceuticals worth $15K as of Q2 2022.
  • RBC Europe left its Teva Pharmaceuticals share count unchanged in Q2 2022.
  • Teva Pharmaceuticals made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #459 holding.
  • RBC Europe first reported a position in Teva Pharmaceuticals in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Teva Pharmaceuticals position peaked at $578K in Q2 2018.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.